We suggest that the HDAC6 expression in HGSOC may have dichotomized the HGSOC samples into molecularly distinct subtypes where low HDAC6 associated with hard-to-treat cancers and high HDAC6 with more treatable cancers. The gene discussed is HDAC6; the disease is cancer.